• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟哌啶醇对自闭症儿童的长期疗效:持续用药与间断用药对比

Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.

作者信息

Perry R, Campbell M, Adams P, Lynch N, Spencer E K, Curren E L, Overall J E

出版信息

J Am Acad Child Adolesc Psychiatry. 1989 Jan;28(1):87-92. doi: 10.1097/00004583-198901000-00016.

DOI:10.1097/00004583-198901000-00016
PMID:2914841
Abstract

The aim of this study was to evaluate the long-term efficacy of haloperidol in autistic children and to determine whether discontinuous drug administration was as effective as continuous drug administration. Sixty children, 48 males and 12 females, ages 2.3 to 7.9 years (X 5.1) completed the study. They received haloperidol over a period of 6 months followed by a 4-week drug withdrawal/placebo period. Haloperidol remained effective, and the discontinuous treatment schedule did not diminish its efficacy. Children with prominent symptoms of irritability, angry and labile affect, and uncooperativeness were the best responders to haloperidol.

摘要

本研究的目的是评估氟哌啶醇对自闭症儿童的长期疗效,并确定间断给药是否与连续给药同样有效。60名儿童(48名男性和12名女性),年龄在2.3至7.9岁之间(平均5.1岁)完成了该研究。他们接受了为期6个月的氟哌啶醇治疗,随后是4周的停药/安慰剂期。氟哌啶醇仍然有效,间断治疗方案并未降低其疗效。具有明显易怒、情绪愤怒和不稳定以及不合作症状的儿童对氟哌啶醇反应最佳。

相似文献

1
Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.氟哌啶醇对自闭症儿童的长期疗效:持续用药与间断用药对比
J Am Acad Child Adolesc Psychiatry. 1989 Jan;28(1):87-92. doi: 10.1097/00004583-198901000-00016.
2
Haloperidol withdrawal and weight changes in autistic children.氟哌啶醇撤药与自闭症儿童的体重变化
Psychopharmacol Bull. 1993;29(2):287-91.
3
Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study.
J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):835-43. doi: 10.1097/00004583-199706000-00022.
4
Factors related to haloperidol response and dyskinesias in autistic children.
Psychopharmacol Bull. 1991;27(2):119-26.
5
Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.赛庚啶治疗孤独症谱系障碍:一项双盲安慰剂对照试验。
J Clin Pharm Ther. 2004 Apr;29(2):145-50. doi: 10.1111/j.1365-2710.2004.00546.x.
6
Neuroleptic-related dyskinesias in autistic children: a prospective study.
Psychopharmacol Bull. 1985;21(1):140-3.
7
Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.利培酮:新适应症。自闭症或智力残疾儿童的行为障碍:无进展。
Prescrire Int. 2006 Apr;15(82):43-5.
8
Tourette-like symptoms associated with neuroleptic therapy in an autistic child.
J Am Acad Child Adolesc Psychiatry. 1989 Jan;28(1):93-6. doi: 10.1097/00004583-198901000-00017.
9
Repeated episodes of neuroleptic-related dyskinesias in autistic children.
Psychopharmacol Bull. 1991;27(2):113-7.
10
Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.氟哌啶醇相关的运动障碍以及自闭症儿童的围产期并发症。
Psychopharmacol Bull. 1995;31(2):363-9.

引用本文的文献

1
Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials.自闭症谱系障碍的药物治疗,包括值得进行试验的有前景的老药。
World J Psychiatry. 2023 Jun 19;13(6):262-277. doi: 10.5498/wjp.v13.i6.262.
2
Therapeutic effects of antidepressants for global improvement and subdomain symptoms of autism spectrum disorder: a systematic review and meta-analysis.抗抑郁药治疗自闭症谱系障碍的整体改善和亚症状的疗效:系统评价和荟萃分析。
J Psychiatry Neurosci. 2022 Aug 10;47(4):E299-E310. doi: 10.1503/jpn.210191. Print 2022 Jul-Aug.
3
Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis.
抗精神病药对自闭症谱系障碍儿童和青少年的影响:系统评价和荟萃分析。
Health Qual Life Outcomes. 2021 Jan 25;19(1):33. doi: 10.1186/s12955-021-01669-0.
4
Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update.抗精神病药在儿童和青少年中的危害:系统评价更新。
Can J Psychiatry. 2018 Oct;63(10):661-678. doi: 10.1177/0706743718779950. Epub 2018 Jun 4.
5
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.抗精神病药物的减量和/或停用以及抗精神病药物作为迟发性运动障碍的特定治疗方法。
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD000459. doi: 10.1002/14651858.CD000459.pub3.
6
Treatment of Autism Spectrum Disorder in Children and Adolescents.儿童和青少年自闭症谱系障碍的治疗
Psychopharmacol Bull. 2016 Aug 15;46(2):18-41.
7
Aggression in autism spectrum disorder: presentation and treatment options.自闭症谱系障碍中的攻击行为:表现及治疗选择
Neuropsychiatr Dis Treat. 2016 Jun 23;12:1525-38. doi: 10.2147/NDT.S84585. eCollection 2016.
8
Pharmacological therapies for autism spectrum disorder: a review.自闭症谱系障碍的药物治疗:综述
P T. 2015 Jun;40(6):389-97.
9
Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children.药物治疗方案对自闭症儿童易怒症状的疗效及耐受性
Clin Med Insights Pediatr. 2014 May 25;8:17-30. doi: 10.4137/CMPed.S8304. eCollection 2014.
10
Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.针对自闭症谱系障碍相关行为症状的全生命周期药物治疗。
Dialogues Clin Neurosci. 2012 Sep;14(3):263-79. doi: 10.31887/DCNS.2012.14.3/cdoyle.